Poster Comprehensive preclinical study on GI-101, a novel CD80-IgG4-IL2 variant protein, as a therapeutic antibody candidate with bispecific immuno-oncology target
페이지 정보
작성자 DAAN
조회 269회 작성일 24-02-16 16:20
조회 269회 작성일 24-02-16 16:20
본문
| Journal | AACR |
|---|---|
| Name | 표경호, 신춘봉, 김재환 |
| Year | 2021 |
첨부파일
-
2021-AACR-Poster-GI.pdf (8.2M)
0회 다운로드 | DATE : 2024-02-16 16:20:07
- 이전글Incorporation of SKI-G-801, novel AXL inhibitor, with anti-PD-1 inhibitor plus chemotherapy improved anti-tumor activity and survival outcome via enhancing antitumor T cell immunity 24.02.16
- 다음글YH29407, a novel IDO1 inhibitor, enhances the anti-tumor effects through increased tumor-reactive T cell functions in solid tumor 24.02.16